HEADER HORMONE/GROWTH FACTOR RECEPTOR 31-JAN-03 1NUO TITLE TWO RTH MUTANTS WITH IMPAIRED HORMONE BINDING COMPND MOL_ID: 1; COMPND 2 MOLECULE: THYROID HORMONE RECEPTOR BETA-1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: THRB OR NR1A2 OR ERBA2 OR THR1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 DE3 PLYSS; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28A KEYWDS ALPHA HELIX, NUCLEAR RECEPTOR, LIGAND BINDING DOMAIN, HORMONE-GROWTH KEYWDS 2 FACTOR RECEPTOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR B.R.HUBER,B.SANDLER,B.L.WEST,S.T.CUNHA-LIMA,H.T.NGUYEN,J.W.APRILETTI, AUTHOR 2 J.D.BAXTER,R.J.FLETTERICK REVDAT 4 03-APR-24 1NUO 1 REMARK REVDAT 3 14-FEB-24 1NUO 1 REMARK SEQADV REVDAT 2 24-FEB-09 1NUO 1 VERSN REVDAT 1 15-APR-03 1NUO 0 JRNL AUTH B.R.HUBER,B.SANDLER,B.L.WEST,S.T.CUNHA-LIMA,H.T.NGUYEN, JRNL AUTH 2 J.W.APRILETTI,J.D.BAXTER,R.J.FLETTERICK JRNL TITL TWO RESISTANCE TO THYROID HORMONE MUTANTS WITH IMPAIRED JRNL TITL 2 HORMONE BINDING JRNL REF MOL.ENDOCRINOL. V. 17 643 2003 JRNL REFN ISSN 0888-8809 JRNL PMID 12554782 JRNL DOI 10.1210/ME.2002-0095 REMARK 2 REMARK 2 RESOLUTION. 3.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.7 REMARK 3 NUMBER OF REFLECTIONS : 5510 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.257 REMARK 3 R VALUE (WORKING SET) : 0.252 REMARK 3 FREE R VALUE : 0.302 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 683 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1887 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 21 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 61.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): NULL REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1NUO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-FEB-03. REMARK 100 THE DEPOSITION ID IS D_1000018220. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97 REMARK 200 MONOCHROMATOR : DOUBLE-CRYSTAL SILICON (111) REMARK 200 MONOCHROMATOR WITH A FIXED- REMARK 200 HEIGHT EXIT BEAM REMARK 200 OPTICS : A FRONT END, VERTICALLY REMARK 200 COLLIMATING PREMIRROR, DOUBLE- REMARK 200 CRYSTAL SILICON (111) REMARK 200 MONOCHROMATOR WITH A FIXED- REMARK 200 HEIGHT EXIT BEAM, TOROIDAL REMARK 200 FOCUSING MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14845 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.0 REMARK 200 DATA REDUNDANCY : 7.530 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : 0.09900 REMARK 200 FOR THE DATA SET : 19.7700 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: THYROID HORMONE RECEPTOR BETA LBD WITH TRIAC BOUND REMARK 200 (UNPUBLISHED) REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.28 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.88 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 800 MM SODIUM ACETATE, 100MM SODIUM REMARK 280 CACODYLATE, PH 7.6, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 43.37367 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 86.74733 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 86.74733 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 43.37367 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLN A 234A REMARK 465 ALA A 253 REMARK 465 PRO A 254 REMARK 465 ILE A 255 REMARK 465 VAL A 256 REMARK 465 ASN A 257 REMARK 465 ALA A 258 REMARK 465 PRO A 259 REMARK 465 GLU A 260 REMARK 465 GLY A 261 REMARK 465 GLY A 262 REMARK 465 LYS A 263 REMARK 465 VAL A 264 REMARK 465 ASP A 461 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 203 CG CD OE1 OE2 REMARK 470 LYS A 206 CG CD CE NZ REMARK 470 HIS A 210 CG ND1 CD2 CE1 NE2 REMARK 470 LYS A 211 CG CD CE NZ REMARK 470 ASP A 216 CG OD1 OD2 REMARK 470 GLU A 217 CG CD OE1 OE2 REMARK 470 GLU A 220 CG CD OE1 OE2 REMARK 470 LYS A 223 CG CD CE NZ REMARK 470 GLU A 227 CG CD OE1 OE2 REMARK 470 SER A 236 OG REMARK 470 LYS A 241 CG CD CE NZ REMARK 470 GLN A 251 CG CD OE1 NE2 REMARK 470 GLU A 267 CG CD OE1 OE2 REMARK 470 LYS A 274 CG CD CE NZ REMARK 470 THR A 281 OG1 CG2 REMARK 470 ARG A 282 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 288 CG CD CE NZ REMARK 470 ASP A 322 CG OD1 OD2 REMARK 470 LYS A 394 CG CD CE NZ REMARK 470 THR A 448 OG1 CG2 REMARK 470 GLU A 449 CG CD OE1 OE2 REMARK 470 GLU A 457 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O PRO A 212 ND2 ASN A 408 2.15 REMARK 500 O MET A 310 OG SER A 314 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 ILE A 222 C ILE A 222 O -0.117 REMARK 500 ASN A 233 CA ASN A 233 C 0.158 REMARK 500 ARG A 282 CA ARG A 282 CB 0.147 REMARK 500 LYS A 289 C LYS A 289 O 0.123 REMARK 500 CYS A 298 CB CYS A 298 SG 0.167 REMARK 500 SER A 314 C SER A 314 O 0.125 REMARK 500 VAL A 319 CA VAL A 319 CB -0.146 REMARK 500 TYR A 321 CZ TYR A 321 CE2 -0.109 REMARK 500 VAL A 370 CB VAL A 370 CG1 -0.131 REMARK 500 ASP A 382 CB ASP A 382 CG 0.157 REMARK 500 ARG A 383 CG ARG A 383 CD -0.165 REMARK 500 TYR A 406 CZ TYR A 406 CE2 -0.106 REMARK 500 PHE A 417 CE1 PHE A 417 CZ -0.141 REMARK 500 TRP A 418 CG TRP A 418 CD1 -0.090 REMARK 500 CYS A 434 C CYS A 434 O -0.160 REMARK 500 PHE A 439 CE1 PHE A 439 CZ -0.114 REMARK 500 GLU A 445 CD GLU A 445 OE1 0.086 REMARK 500 PHE A 459 CZ PHE A 459 CE2 -0.129 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 CYS A 298 CA - CB - SG ANGL. DEV. = 13.3 DEGREES REMARK 500 ASP A 300 CB - CG - OD2 ANGL. DEV. = 7.4 DEGREES REMARK 500 GLU A 311 OE1 - CD - OE2 ANGL. DEV. = -7.3 DEGREES REMARK 500 ASP A 367 CB - CG - OD2 ANGL. DEV. = 9.0 DEGREES REMARK 500 ASP A 382 CB - CG - OD1 ANGL. DEV. = 12.2 DEGREES REMARK 500 ARG A 391 NE - CZ - NH1 ANGL. DEV. = 4.5 DEGREES REMARK 500 ASP A 427 CB - CG - OD2 ANGL. DEV. = 7.9 DEGREES REMARK 500 CYS A 446 CA - CB - SG ANGL. DEV. = 6.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 202 -68.33 -93.52 REMARK 500 THR A 232 22.19 -147.79 REMARK 500 HIS A 237 24.68 -148.99 REMARK 500 LEU A 266 -32.13 73.26 REMARK 500 HIS A 271 -73.52 -42.10 REMARK 500 LYS A 274 -78.25 -51.96 REMARK 500 ILE A 275 31.93 -59.56 REMARK 500 ARG A 320 52.02 -91.37 REMARK 500 GLU A 324 -86.42 -64.92 REMARK 500 ASN A 331 25.39 49.96 REMARK 500 LYS A 342 -78.50 -61.43 REMARK 500 ASN A 343 -7.97 -51.42 REMARK 500 MET A 358 -9.37 -56.34 REMARK 500 SER A 361 26.85 -65.00 REMARK 500 VAL A 389 -73.28 -69.80 REMARK 500 LYS A 411 71.46 35.89 REMARK 500 HIS A 413 63.72 -119.06 REMARK 500 VAL A 444 -125.36 -80.70 REMARK 500 GLU A 445 -2.07 58.96 REMARK 500 CYS A 446 69.21 84.26 REMARK 500 PRO A 447 -126.63 -28.45 REMARK 500 THR A 448 -169.75 36.93 REMARK 500 GLU A 449 -166.08 39.65 REMARK 500 LEU A 450 48.37 7.96 REMARK 500 PRO A 452 139.63 -31.93 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 4HY A 500 DBREF 1NUO A 201 461 UNP P10828 THB1_HUMAN 201 461 SEQADV 1NUO ASP A 247 UNP P10828 GLU 248 CONFLICT SEQADV 1NUO HIS A 316 UNP P10828 ARG 316 VARIANT SEQRES 1 A 261 MET GLU GLU LEU GLN LYS SER ILE GLY HIS LYS PRO GLU SEQRES 2 A 261 PRO THR ASP GLU GLU TRP GLU LEU ILE LYS THR VAL THR SEQRES 3 A 261 GLU ALA HIS VAL ALA THR ASN ALA GLN GLY SER HIS TRP SEQRES 4 A 261 LYS GLN LYS ARG LYS PHE LEU PRO ASP ASP ILE GLY GLN SEQRES 5 A 261 ALA PRO ILE VAL ASN ALA PRO GLU GLY GLY LYS VAL ASP SEQRES 6 A 261 LEU GLU ALA PHE SER HIS PHE THR LYS ILE ILE THR PRO SEQRES 7 A 261 ALA ILE THR ARG VAL VAL ASP PHE ALA LYS LYS LEU PRO SEQRES 8 A 261 MET PHE CYS GLU LEU PRO CYS GLU ASP GLN ILE ILE LEU SEQRES 9 A 261 LEU LYS GLY CYS CYS MET GLU ILE MET SER LEU HIS ALA SEQRES 10 A 261 ALA VAL ARG TYR ASP PRO GLU SER GLU THR LEU THR LEU SEQRES 11 A 261 ASN GLY GLU MET ALA VAL THR ARG GLY GLN LEU LYS ASN SEQRES 12 A 261 GLY GLY LEU GLY VAL VAL SER ASP ALA ILE PHE ASP LEU SEQRES 13 A 261 GLY MET SER LEU SER SER PHE ASN LEU ASP ASP THR GLU SEQRES 14 A 261 VAL ALA LEU LEU GLN ALA VAL LEU LEU MET SER SER ASP SEQRES 15 A 261 ARG PRO GLY LEU ALA CYS VAL GLU ARG ILE GLU LYS TYR SEQRES 16 A 261 GLN ASP SER PHE LEU LEU ALA PHE GLU HIS TYR ILE ASN SEQRES 17 A 261 TYR ARG LYS HIS HIS VAL THR HIS PHE TRP PRO LYS LEU SEQRES 18 A 261 LEU MET LYS VAL THR ASP LEU ARG MET ILE GLY ALA CYS SEQRES 19 A 261 HIS ALA SER ARG PHE LEU HIS MET LYS VAL GLU CYS PRO SEQRES 20 A 261 THR GLU LEU PHE PRO PRO LEU PHE LEU GLU VAL PHE GLU SEQRES 21 A 261 ASP HET 4HY A 500 21 HETNAM 4HY [4-(4-HYDROXY-3-IODO-PHENOXY)-3,5-DIIODO-PHENYL]-ACETIC HETNAM 2 4HY ACID FORMUL 2 4HY C14 H9 I3 O4 HELIX 1 1 MET A 201 ILE A 208 1 8 HELIX 2 2 THR A 215 ALA A 231 1 17 HELIX 3 3 HIS A 237 ARG A 242 1 6 HELIX 4 4 LEU A 266 ILE A 275 1 10 HELIX 5 5 ILE A 276 LEU A 290 1 15 HELIX 6 6 LEU A 290 GLU A 295 1 6 HELIX 7 7 PRO A 297 ARG A 320 1 24 HELIX 8 8 THR A 337 ASN A 343 1 7 HELIX 9 9 GLY A 347 SER A 361 1 15 HELIX 10 10 ASP A 366 MET A 379 1 14 HELIX 11 11 CYS A 388 LYS A 411 1 24 HELIX 12 12 HIS A 416 VAL A 444 1 29 HELIX 13 13 PRO A 452 GLU A 460 1 9 SHEET 1 A 4 LYS A 243 PHE A 244 0 SHEET 2 A 4 MET A 334 VAL A 336 1 O ALA A 335 N LYS A 243 SHEET 3 A 4 THR A 327 LEU A 330 -1 N LEU A 330 O MET A 334 SHEET 4 A 4 TYR A 321 ASP A 322 -1 N ASP A 322 O THR A 327 SITE 1 AC1 11 PHE A 272 ILE A 276 ALA A 279 MET A 310 SITE 2 AC1 11 MET A 313 HIS A 316 ASN A 331 LEU A 346 SITE 3 AC1 11 ILE A 353 HIS A 435 PHE A 455 CRYST1 67.274 67.274 130.121 90.00 90.00 120.00 P 31 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014865 0.008582 0.000000 0.00000 SCALE2 0.000000 0.017164 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007685 0.00000